National Center for Complementary, 2013-06-19: A federal trial combining gemcitabine with mistletoe extract in advanced solid tumours, sponsored by NCCIH with information supplied by NCI; the record shows the study as terminated and last updated in June 2013.
RATIONALE: Drugs used in chemotherapy, such as gemcitabine, use different ways to stop tumor cells from dividing so they stop growing or die. Mistletoe may slow the growth of tumor cells
Brief Summary, unpaginated
National Center for Complementary, 2013-06-19: A federal trial combining gemcitabine with mistletoe extract in advanced solid tumours, sponsored by NCCIH with information supplied by NCI; the record shows the study as terminated and last updated in June 2013. Directly answers the request for a federal mistletoe trial: NCCIH (not NCI) is the lead sponsor, with NCI providing the record. Status: Terminated. Comparator: the trial design combined mistletoe with chemotherapy rather than testing it as an alternative. Record last update posted 2013-06-19. Document date is the retrieval date. QUOTE NOTE: the excerpt is the registry's brief summary as rendered; the wording was read from the page on 2026-11-18.
